AI Hunt for ALS Treatment Continues With 28 Novel Targets Revealed by Insilico Medicine
Insilico Medicine identified 28 new targets for the treatment of amyotrophic lateral sclerosis (ALS) using its proprietary AI-driven platform PandaOmics. Previously unreported 8 genes were shown to have functional connection with ALS and 64% of identified targets were successfully validated in a preclinical animal model. This gives a hope to solve an unmet need for ALS treatment.
This content available exclusively for BPT Mebmers
Topics: Novel Therapeutics
There are no comments yet. You can be the first.
Leave a Reply cancel reply
Your email address will not be published. Required fields are marked *